MedPath

Safety testing of cosmetic product using Patch Test

Recruiting
Conditions
Skin irritation test
Registration Number
CTRI/2021/07/035262
Lead Sponsor
Entice Supplements Pvt Ltd
Brief Summary

The patch test is the most common technique to evaluate a product tolerance on human skin. There are various methods of patch test which differ on the study objectives. The most common method is single application occlusive patch test for 24 hrs followed by observation after 48 hrs after application also. This method is a very common method in dermatological & inhalation practice to evaluate any intolerance which can result in acute dermatitis.

The current study objective isevaluation of dermatological safety and adverse reaction of Entice GlowMoisturizer for dermatological safety by 24 hrs patch test under completeocclusion on healthy human subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
24
Inclusion Criteria
  • 1.Subjects in age group 18.
  • 55 years (both the ages inclusive). 2.Healthy male & female subjects. 3.Subjects with Fitzpatrick skin type III to V. 4.Subjects willing to give a written informed consent. 5.Subjects willing to maintain the patch test in position for 24 hours. 6.Subject having not participated in a similar investigation in the past one month. 7.Subjects willing to come for regular follow up visits. 8.Subjects ready to follow instructions during the study period. Test period:9 days for all subjects including screening day.
Exclusion Criteria
  • 1.Infection, allergy on the tested area.
  • 2.Skin allergy, antecedents or atopic subjects.
  • 3.Athletes and subjects with history of excessive sweating.
  • 4.Cutaneous disease which may influence the study result.
  • 5.Subjects on oral corticosteroid .
  • 6.Subjects participating in any other cosmetic or therapeutic study.
  • 7.Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The objective of this study is to evaluate the dermatological safety of the given investigational product/s on skin of healthy human volunteers by dermatological visual assessment24 hrs
Secondary Outcome Measures
NameTimeMethod
Adverse event monitoring0 hr to 24 hrs

Trial Locations

Locations (1)

Sigma Skin & Cosmetology Clinic

🇮🇳

Bangalore, KARNATAKA, India

Sigma Skin & Cosmetology Clinic
🇮🇳Bangalore, KARNATAKA, India
DrMadan Mohan N T
Principal investigator
9845074316
drmadan1969@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.